WELL Health Technologies Corp.
WHTCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -117.01 | -4.42 | -0.03 |
| FCF Yield | -0.39% | 6.39% | 11.30% | 2.09% |
| EV / EBITDA | 17.34 | 14.19 | 9.79 | 39.85 |
| Quality | ||||
| ROIC | -6.72% | 2.28% | 2.02% | -1.34% |
| Gross Margin | 39.47% | 47.97% | 53.29% | 50.84% |
| Cash Conversion Ratio | 0.33 | 810.21 | 4.10 | -0.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 17.35% | 36.92% | 124.59% | 109.65% |
| Free Cash Flow Growth | -111.49% | -16.84% | 258.12% | 400.55% |
| Safety | ||||
| Net Debt / EBITDA | 2.51 | 4.19 | 3.26 | 10.62 |
| Interest Coverage | -0.85 | 1.07 | 1.04 | -1.69 |
| Efficiency | ||||
| Inventory Turnover | 206.87 | 342.19 | 194.05 | 187.43 |
| Cash Conversion Cycle | 24.60 | 9.62 | -3.25 | -6.41 |